9,284
Participants
Start Date
April 15, 2020
Primary Completion Date
December 31, 2020
Study Completion Date
December 31, 2020
Long-acting Muscarinic Antagonists (LAMA)
drug
Inhaled corticosteroid (ICS)/Long-acting Beta Agonists (LABA)
drug
Konkuk University Medical Center, Seoul
Lead Sponsor
Boehringer Ingelheim
INDUSTRY